551 related articles for article (PubMed ID: 17765643)
1. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
[TBL] [Abstract][Full Text] [Related]
2. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
3. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
Almagor M; Keren A; Banai S
Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
[TBL] [Abstract][Full Text] [Related]
4. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty.
Tarantini G; Napodano M; Gasparetto N; Favaretto E; Marra MP; Cacciavillani L; Bilato C; Osto E; Cademartiri F; Musumeci G; Corbetti F; Razzolini R; Iliceto S
Coron Artery Dis; 2010 Mar; 21(2):78-86. PubMed ID: 20071979
[TBL] [Abstract][Full Text] [Related]
5. Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation.
Delhaye C; Maluenda G; Wakabayashi K; Ben-Dor I; Lemesle G; Collins SD; Syed AI; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am J Cardiol; 2010 Mar; 105(6):826-32. PubMed ID: 20211326
[TBL] [Abstract][Full Text] [Related]
6. Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions.
Kubica J; Kozinski M; Krzewina-Kowalska A; Zbikowska-Gotz M; Dymek G; Sukiennik A; Piasecki R; Bogdan M; Grzesk G; Chojnicki M; Dziedziczko A; Sypniewska G
Int J Mol Med; 2005 Jul; 16(1):173-80. PubMed ID: 15942695
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
9. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris.
Saleh N; Svane B; Jensen J; Hansson LO; Nordin M; Tornvall P
Am Heart J; 2005 May; 149(5):876-82. PubMed ID: 15894971
[TBL] [Abstract][Full Text] [Related]
10. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ
Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447
[TBL] [Abstract][Full Text] [Related]
11. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization.
Susen S; Sautière K; Mouquet F; Cuilleret F; Chmaït A; McFadden EP; Hennache B; Richard F; de Groote P; Lablanche JM; Dallongeville J; Bauters C; Jude B; Van Belle E
Eur Heart J; 2005 Nov; 26(22):2387-95. PubMed ID: 16105849
[TBL] [Abstract][Full Text] [Related]
12. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.
Segev A; Kassam S; Buller CE; Lau HK; Sparkes JD; Connelly PW; Seidelin PH; Natarajan MK; Cohen EA; Strauss BH
Eur Heart J; 2004 Jun; 25(12):1029-35. PubMed ID: 15191773
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
[TBL] [Abstract][Full Text] [Related]
14. Are drug-eluting stents indicated in large coronary arteries? Insights from a multi-centre percutaneous coronary intervention registry.
Yan BP; Ajani AE; New G; Duffy SJ; Farouque O; Shaw J; Sebastian M; Lew R; Brennan A; Andrianopoulos N; Reid C; Clark DJ;
Int J Cardiol; 2008 Nov; 130(3):374-9. PubMed ID: 18706719
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
[TBL] [Abstract][Full Text] [Related]
16. Residual high-grade angina after enhanced external counterpulsation therapy.
McCullough PA; Henry TD; Kennard ED; Kelsey SF; Michaels AD;
Cardiovasc Revasc Med; 2007; 8(3):161-5. PubMed ID: 17765644
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty.
de Winter RJ; Heyde GS; Koch KT; Fischer J; van Straalen JP; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; Piek JJ; Tijssen JG
Eur Heart J; 2002 Jun; 23(12):960-6. PubMed ID: 12069451
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
[TBL] [Abstract][Full Text] [Related]
20. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents.
Niccoli G; Schiavino D; Belloni F; Ferrante G; La Torre G; Conte M; Cosentino N; Montone RA; Sabato V; Burzotta F; Trani C; Leone AM; Porto I; Pieroni M; Patriarca G; Crea F
Eur Heart J; 2009 Jun; 30(11):1340-7. PubMed ID: 19383735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]